III. Contraindications
IV. Mechanism
V. Dosing
- Take 2 mg orally once daily
- Decrease dose to 1 mg/day in eGFR <30 ml/min
VI. Adverse Effects
VII. Safety
- Unknown safety in pregnancy
- Unknown safety in Lactation
VIII. Resources
IX. References
- Olson (2020) Clinical Pharmacology, Medmaster Miami, p. 98
- Hamilton (2020) Tarascon Pocket Pharmacopoeia
Images: Related links to external sites (from Bing)
Related Studies
motegrity (on 1/3/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
MOTEGRITY 1 MG TABLET | $15.64 each | |
MOTEGRITY 2 MG TABLET | $15.58 each |
Ontology: prucalopride (C0913506)
Concepts | Pharmacologic Substance (T121) , Organic Chemical (T109) |
MSH | C406662 |
SnomedCT | 699273008 |
English | prucalopride, Prucalopride, Prucalopride (substance), PRUCALOPRIDE, resotrans, resotran |
Spanish | prucaloprida (sustancia), prucaloprida |